We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NICE Denies Cordis Appeal on Drug-Eluting Stents
NICE Denies Cordis Appeal on Drug-Eluting Stents
August 1, 2008
A UK National Institute for Health and Clinical Excellence (NICE) panel has denied an appeal from Cordis, a unit of Johnson & Johnson (J&J) Medical Ltd., regarding reimbursement for drug-eluting stents used to treat coronary artery disease.